Redding, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) — According to a new market research report ‘Direct-to-consumer laboratory testing market by application (genetic testing, COVID-19, diabetes, STD, risk assessment, cancer, routine testing, CBC, CNS, TSH), sample type (saliva, urine, blood, nasopharynx, faeces) – Global Forecast to 2029,‘ published by Meticulous Research®The DTC laboratory testing market is projected to reach US$14.61 billion by 2029 at a CAGR of 21.2% over the forecast period 2022-2029.
Download a free report sample now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5351
DTC testing allows consumers to order lab tests without the involvement of their healthcare provider. The results obtained from these tests can be used to monitor existing health conditions, identify unknown medical conditions, and gather data about personal characteristics. There is an increasing prevalence of chronic diseases across the world which is expected to drive the growth of the DTC laboratory testing market. For example, according to the International Agency for Research on Cancer, it is estimated that the number of new cancer cases in Asia will increase from 9.5 million in 2020 to about 12.3 million by 2030. In Europe, there will also be 4.9 million cancer cases by 2030, up from 4.3 million in 2020.
Due to several regulations and restrictions, people could not independently order a lab test without a doctor’s approval. With the advent of DTC testing, people can now order lab tests directly without the involvement of their doctors. The DTC testing industry has seen significant growth attributed to people’s increasing involvement in their healthcare decisions and their exploration of new ways to participate in decisions affecting their healthcare. This is expected to continue to drive the growth of the DTC laboratory test marker in the future.
Effects of the COVID-19 pandemic on the DTC…
